Heart Valve News
-
Survivors of childhood cancers are likely to have chronic ailments such as lower lung function and heart conditions that require medical attention as they become adults, researchers said.
-
Arena Pharmaceuticals Inc., the maker of the weight-loss drug Belviq, said it is withdrawing its application to gain regulatory approval in Europe for the obesity medicine.
-
Abbott Laboratories and Johnson & Johnson , pursuing a potential $2 billion market for heart valves that don’t require rib-cracking surgery, are shopping for companies with the new technology.
-
Abbott Laboratories’ proposed clamp for leaky heart valves, a less-invasive option to open-chest surgery, may not be effective, U.S. regulatory advisers said.
-
Medtronic Inc. sued Edwards Lifesciences Corp. in two U.S. lawsuits accusing the company of infringing patents on a heart valve system.
-
Edwards Lifesciences Corp. accepted restrictions on its Sapien heart valve that may cut U.S. sales $100 million in 2015 in exchange for guarantees Medicare will pay for its use in patients too sick for chest-opening surgery.
-
Edwards Lifesciences Corp.’s Sapien, used to replace a damaged aortic valve, will be covered by the U.S. government’s Medicare program.
-
The first man on the moon, the first U.S. woman in space and the first black Federal Reserve member were among the notable deaths in 2012.
-
Medtronic Inc. ’s CoreValve unit didn’t infringe Edwards Lifesciences Corp.’s European patent for artificial heart-valve technology, a U.K. appeals court ruled.
-
A half decade after Edwards Lifesciences Corp. and Medtronic Inc. introduced devices in Europe that make heart-valve surgery easier to endure, most U.S. patients are waiting for safety data to clear their use.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page